Status:

RECRUITING

A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers

Lead Sponsor:

Jonsson Comprehensive Cancer Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Colorectal Carcinoma

Eligibility:

All Genders

Phase:

NA

Brief Summary

This clinical trial evaluates a clinic-wide intervention called Primary Care-Gastrointestinal (GI) Connect for improving follow-up colonoscopy rates in patients at a Federally Qualified Health Center ...

Detailed Description

PRIMARY OBJECTIVES: I. Conduct a pragmatic, cluster randomized trial in 6 clinics (1500 patients) within a multi-site FQHC system to compare the effectiveness of the multilevel FQHC-GI care coordinat...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • 6 adult care NEVHC clinic sites

Exclusion

    Key Trial Info

    Start Date :

    April 22 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 31 2029

    Estimated Enrollment :

    1500 Patients enrolled

    Trial Details

    Trial ID

    NCT06568016

    Start Date

    April 22 2025

    End Date

    August 31 2029

    Last Update

    June 12 2025

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    University of California at Los Angeles

    Los Angeles, California, United States, 90095-1406

    2

    UCLA / Jonsson Comprehensive Cancer Center

    Los Angeles, California, United States, 90095

    A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers | DecenTrialz